Home›Antianemic preparations›阿法依泊汀🌐中文EnglishBahasa IndonesiaEspañolFrançaisPolskiPortuguêsTürkçeالعربية中文EntityQ5383794· pop 12· linked from 279 articles阿法依泊汀Also known as Epogen, Procrit, EPO, Erythropoietin precursorpharmaceutical drugResearch2,506 papersEpoetin alfa biosimilar (HX575): A review of 15 years' post-approval clinical experience.Critical reviews in oncology/hematology · 2023Epoetin-alfa induced pruritic maculopapular eruption: Case report and literature review.Asian Pacific journal of allergy and immunology · 2023Epoetin alfa for the treatment of myelodysplastic syndrome-related anemia: A review of clinical data, clinical guidelines, and treatment protocols.Leukemia research · 2019Epoetin alfa as a supportive measure in hematologic malignancies.Seminars in hematology · 2002Epoetin alfa therapy for patients with hematologic malignancies and mild anemia.Clinical lymphoma · 2003via PubMedAvailable in 12 languagesEspañolFrançais中文PortuguêsالعربيةBahasa IndonesiaOdiaPolskiSerbianSerbian (Latin)UkrainianConnectionsUnited States Food and Drug AdministrationEntitychronic renal insufficiencyEntityCategoriesAntianemic preparationsChemicals that do not have a ChemSpider ID assignedDrugboxes which contain changes to verified fieldsDrugs developed by AmgenDrugs developed by Johnson & JohnsonDrugs with non-standard legal statusErythropoiesis-stimulating agentsGrowth factorsInfobox drug articles without a structure imageRecombinant proteins